Training
BSN at University of Minnesota (2008); MSN with PMHNP track at Case Western Reserve (2015). Five years at a community mental health center in St. Cloud, Minnesota, working primarily with opioid-use-disorder and serious-mental-illness populations. Joined Chronograph in early 2023, six months after the X-waiver was retired.
Member of the American Psychiatric Nurses Association. American Society of Addiction Medicine education member. Trained in low-dose buprenorphine induction through the Boston Medical Center training series and through the PCSS longitudinal mentorship program.
What I do
I run the mental-health lane (Lane 03). The day-to-day work is depression and anxiety pharmacology, ADHD continuation prescriptions for adolescents and adults, medications for opioid use disorder (buprenorphine and, less commonly, naltrexone), and the practice's coordination with the four therapists we refer to most often. I write the case logs in this lane.
I do not do psychotherapy. I am credentialed to; I do not, in this practice, because the math of the day works better with the therapists in town doing the therapy and me doing the medication, and because the therapists are excellent at what they do. The warm handoff is the unit of cooperation; it is a phone call.
A working stance
Two stances I argue for, repeatedly, in this practice and in our transcripts. First: medications for opioid use disorder are, in 2026, primary-care work. The X-waiver is gone, the literature supports it, and the patients do better with their primary-care clinician than with a separate addiction-medicine pipeline that they may have no other reason to enter. Second: depression in primary care should be treated with the same seriousness as hypertension. Half the antidepressants written in the United States are written by primary-care clinicians; we should be unembarrassed by that fact and we should do it well.
I do not pretend to be a substitute for psychiatry where psychiatry is what is needed. The members of our panel with severe or treatment-resistant illness are co-managed with our consulting psychiatrist Dr. Maya Cassirer, MD, who carries a small consultation panel with us. Dr. Cassirer is not on staff; she takes phone calls from us with a 24-hour return SLA, and we are grateful for it.
Availability
Member-facing hours: Monday/Tuesday/Thursday 07:30–18:00, Wednesday morning, alternating Saturdays. Acute-induction availability for buprenorphine is held open in the schedule on Tuesdays and Thursdays; we do not require a member to wait three weeks for a first OUD visit.
Cross-references: most of my visits are in Lane 03; my transcript is "Buprenorphine without theater"; case log 004 is a worked low-dose induction.